MAP2 is typically detected using immunohistochemistry (IHC) or immunofluorescence techniques. These methods involve the use of specific antibodies that bind to MAP2, allowing visualization of its distribution within the tissue. In IHC, the antibody binding is visualized using chromogenic substrates, while in immunofluorescence, fluorescent dyes are used. These techniques enable detailed examination of neuronal structures under a microscope.
